Publication date: Aug 29, 2018 Buprenorphine is usually administered to treat opioid use disorder and pain syndromes. This research presents the first study regarding the effectiveness of different singly administered ... Read more

Publication date: Aug 27, 2018 Suicide is a leading cause of death in Huntington’s disease (HD), following pneumonia. Up to one-fifth of individuals with HD report suicidal ideation. Identifying the ... Read more

Publication date: Jun 17, 2018 INTRODUCTION: Psychiatric disorders frequently occur in patients with multiple sclerosis (MS); however, limited reports are available on these comorbidities. We aimed to investigate the relationships ... Read more

Publication date: Mar 01, 2018 Huntington’s disease (HD) gene expansion carriers are at an increased risk of suicide, but so far, no studies have investigated the full spectrum of suicidality, ... Read more

Publication date: Mar 01, 2019 Although some studies have examined the association between prescription opioid misuse and mental health outcomes, few studies have examined the effects of prescription opioid misuse ... Read more

Publication date: Mar 05, 2019 Prior research has shown associations between opioid misuse and suicidal behaviors, but the relationship between medical opioid use and suicidal behaviors is not known. We ... Read more

Publication date: Mar 08, 2019 Most suicidality literature in Huntington disease (HD) is based on natural history studies or retrospective reviews, but reports on risk factors from clinical trials are ... Read more

Publication date: Jun 20, 2018 To determine whether tetrabenazine (TBZ) use is associated with an increased incidence of depression and/or suicidal ideation. In this retrospective cross-sectional study of the Enroll-HD ... Read more